Pentoxifylline and Late Onset Sepsis in Preterm Infants
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
- Hypothesis: The investigators hypothesized that Pentoxifylline has potent
anti-inflammatory effect which can augment the antimicrobial effect of antibiotics in
treatment of Late onset sepsis (LOS) in preterm infants thus decreasing neonatal
mortality and morbidity.
- The purpose of this study: to assess the efficacy and safety of Pentoxifylline as an
adjunct to antibiotic therapy on mortality and morbidity of preterm infants with LOS.